Literature DB >> 30038422

High Serum Iron level is Associated with Increased Mortality in Patients with Sepsis.

Peng Lan1, Kong-Han Pan1, Shuo-Jia Wang2, Qiu-Cheng Shi3, Yun-Xian Yu2, Ying Fu4, Yan Chen3, Yan Jiang3, Xiao-Ting Hua3, Jian-Cang Zhou5, Yun-Song Yu3.   

Abstract

Iron is an essential nutrient for bacterial survival and thus higher iron levels may precipitate bacterial infections. We investigated the association between the serum iron level and prognosis in patients with sepsis by using the single-centre Medical Information Mart for Intensive Care III (MIMIC-III) database. Sepsis patients with iron parameters measured on ICU admission were included and stratified according to quartiles of serum iron levels. A total of 1,891 patients diagnosed with sepsis according to the Sepsis-3 criteria were included in this study, 324 of whom were septic shock. After adjusting for confounding variables, higher iron quartile was associated with an increase in 90-day mortality in the Cox regression analysis. Moreover, a stepwise increase in the risk of 90-day mortality was observed as the quartiles of serum iron levels increased in the patients with sepsis. In conclusion, higher serum iron levels were independently associated with increased 90-day mortality in this large cohort of patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30038422      PMCID: PMC6056487          DOI: 10.1038/s41598-018-29353-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Iron plays a pivotal role during infection because it functions as a critical cofactor in a variety of physiological metabolic reactions and is an essential nutrient for bacteria. Thus, during bacterial infections, both the host and bacteria compete for iron to thrive. In the human body, most iron is sequestered by haemoglobin[1]. Meanwhile, iron-binding proteins, antibodies and complement proteins in the body function jointly to retain iron[2]. Nevertheless, both free iron and protein-bound iron can be captured by bacteria through various mechanisms, such as siderophores[2,3], which are secreted by pathogens and possess an affinity to iron that is higher than that of the host transport proteins[4]. Moreover, free iron is toxic because it readily accepts or donates electrons, leading to the generation of reactive oxygen species[5]. Haemochromatosis, a hereditary iron overload condition, is known to cause susceptibility to infection and iron chelators may reverse this susceptibility[6]. Thus, a higher iron level may precipitate infections. Transferrin saturation (TSAT), a parameter reflects iron availability, was recently reported to be associated with prognosis of ICU patients[7]. Therefore, the likelihood that a higher serum iron level in patients with sepsis is associated with a poorer prognosis is an appealing hypothesis; though, few clinical studies were available as to this hypothesis so far. We hypothesized that higher iron level was associated with worse outcomes in patients with sepsis. Thus, we tested the abovementioned hypothesis by analysing a large database and exploring the association between serum iron levels and the 90-day mortality in patients with sepsis.

Results

Characteristics of the study population

A total of 1,891 patients diagnosed with sepsis according to the Sepsis-3 criteria were included in the present study and 324 (17.1%) patients were in septic shock. The baseline characteristics of all patients were presented in Table 1. Half of the patients were male, and approximate two-thirds of the patients were older than 60 years. Most of the patients were admitted from emergency room. One-fifth of the patients were treated by mechanical ventilation upon ICU admission, and the median Simplified Acute Physiology Score (SAPS) II and Sequential Organ Failure Assessment (SOFA) scores were 43 and 5, respectively. With respect to the primary infection sites (Table 2), respiratory, bloodstream and urinary infections accounted for the vast majority of the infections. When it comes to microbiology, Staphylococcus (762, 40.3%) and Escherichia coli (195, 10.3%) were the two leading pathogens.
Table 1

Baseline characteristics and laboratory parameters of the study population.

CharacteristicsTotal cohort (n = 1891)Septic shock cohort (n = 324)
Male, n (%)961 (50.8)162 (50.0)
Age, n (%)
   16–3065 (3.4)4 (1.2)
   31–59581 (30.7)94 (29.0)
   ≥601245 (65.8)226 (69.8)
Admission type, n (%)
   Emergency1809 (95.7)575 (95.4)
   Elective49 (2.6)12 (2.0)
   Urgent33 (1.7)16 (2.7)
Comorbidity, n (%)
   Hypertension729 (38.6)114 (35.2)
   Malignant neoplasm422 (22.3)63 (19.4)
   Diabetes Mellitus591 (31.3)106 (32.7)
   Congestive heart failure694 (36.7)123 (38.0)
SAPS II, median (IQR)43 (35–53)52 (42–61)
SOFA Score, median (IQR)5 (3–8)9 (6–11)
Mechanical ventilation on ICU admission, n (%)308 (16.3)64 (19.8)
Adequate antimicrobial therapy, n (%)1336 (70.7)240 (74.1)
Tight glucose control, n (%)1805 (95.5)304 (93.8)
Hydrocortisone replacement, n (%)188 (9.9)76 (23.5)
Laboratory measurements
   Serum creatinine, median (IQR) (mg/dL)1.3 (0.9–2.2)1.5 (1.1–2.6)
   Lactate, median (IQR) (mmol/L)1.8 (1.3–2.9)3.4 (2.5–4.8)
   Hemoglobin, median (IQR) (g/dL)10.7 (9.4–12.1)11.0 (9.7–12.5)
   Transferrin, median (IQR) (mg/dL)153.0 (119.5–193.5)144.0 (114.8–186.3)
   Ferritin, median (IQR) (ng/mL)350 (157.0–775.0)386.5 (191.8–897.8)
   White blood cell count, median (IQR) (×103/μL)11.5 (8.1–16.6)11.7 (7.4–17.3)

Abbreviations: SOFA score, Sequential Organ Failure Assessment score; SAPS II, Simplified Acute Physiology Score II; IQR, interquartile range.

Table 2

Infection origins and pathogens of the study population.

CharacteristicsTotal cohort (n = 1891)Septic shock cohort (n = 324)
Site of Infection, n (%)a
   Respiratory1051 (55.6)188 (58.0)
   Bloodstream831 (43.9)233 (71.9)
   Urinary741 (39.2)124 (38.3)
   Abdominal262 (13.9)51 (15.7)
   Gastrointestinal161 (8.5)25 (7.7)
   Skin and soft tissue48 (2.5)6 (1.9)
Pathogenic organism, n (%)
   Staphylococcus, coagulase (+)407 (21.5)71 (21.9)
   Staphylococcus, coagulase (−)355 (18.8)62 (19.1)
   Escherichia coli195 (10.3)42 (13.0)
   Pseudomonas aeruginosa124 (6.6)23 (7.1)
   Candida120 (6.3)29 (9.0)
   Klebsiella pneumonia121 (6.4)16 (4.9)
   Streptococcus104 (5.5)19 (5.9)
   Clostridium difficile98 (5.2)13 (4.0)
   Enterococcus faecium31 (1.6)6 (1.9)
   Enterococcus faecalis23 (1.2)7 (2.2)

aPatient may have simultaneously multiple sites of infection.

Baseline characteristics and laboratory parameters of the study population. Abbreviations: SOFA score, Sequential Organ Failure Assessment score; SAPS II, Simplified Acute Physiology Score II; IQR, interquartile range. Infection origins and pathogens of the study population. aPatient may have simultaneously multiple sites of infection.

Outcomes and Cox regression analysis

The median ICU and hospital stays were 3.8 days and 10.6 days, respectively. The overall 28- and 90-day mortality rates were 21.3% and 30.9%, respectively (Table 3). The mortality rates on days 28 and 90 were significantly increased as the iron quartiles increased (p = 0.001 and p < 0.001 for trend, respectively) (Table 3 and Fig. 1). Cox regression models were established to further determine the independent effect of iron levels on prognosis. After adjusting for possible confounding variables, the risk of death on day 90 increased in a stepwise manner as the iron quartiles increased (Table 4 and Fig. 2). Regarding the other iron parameters, transferrin (HR: 0.997, 95% CI: 0.996–0.999, p < 0.001) and haemoglobin (HR: 0.936, 95% CI: 0.899–0.975, p = 0.001) levels exerted a beneficial effect on the mortality of patients with sepsis, whereas ferritin levels had no significant impact on 90-day mortality (HR: 1.000, 95% CI: 0.999–1.000, p = 0.393) (Table 4). For septic shock cohort, the fourth quartiles of iron was associated with increased risk of death after adjustment for confounding factors (HR: 1.524, 95% CI: 1.063–2.186, p = 0.022, Fig. 2).
Table 3

Outcomes of patients according to the quartiles of serum iron.

OutcomesTotal(n = 1891)First quartile(n = 489)Second quartile(n = 461)Third quartile(n = 474)Fourth quartile(n = 467)p value
Mortality (n, %)
   90-day584 (30.9)127 (26.0)134 (29.1)154 (32.5)169 (36.2)<0.001
   28-day402 (21.3)89 (18.2)89 (19.3)95 (20.0)129 (27.6)0.001
   ICU273 (14.4)57 (11.7)62 (13.4)54 (11.4)100 (21.4)<0.001
   Hospital342 (18.1)73 (14.9)76 (16.5)76 (16.0)117 (25.1)<0.001
Length of stay (median days, IQR)
   ICU3.8 (2.0–8.7)4.3 (2.0–9.0)3.9 (2.0–8.9)3.5 (2.0–7.8)3.6 (2.0–8.7)0.468
   Hospital10.6 (6.2–18.0)10.8 (6.5–18.1)10.6 (6.6–17.8)10.3 (6.4–17.4)10.1 (5.8–19.5)0.670

Abbreviations: ICU, intensive care unit; IQR, interquartile range.

Figure 1

Kaplan-Meier curves showing the association between the iron quartiles and the 90-day mortality.

Table 4

Cox proportional hazard models exploring the association of iron quartiles with 90-day mortality.

FactorsUnivariate modelMultivariate model
Hazard ratio (95% CI)p valueHazard ratio (95% CI)p value
Gender (male)1.217 (1.034–1.433)0.0181.067 (0.903–1.260)0.445
Age
   16–30ReferenceReference
   31–591.762 (0.861–3.606)0.1211.383 (0.673–2.842)0.378
   ≥603.555 (1.767–7.151)<0.0012.677 (1.316–5.445)0.007
Diabetes0.989 (0.830–1.179)0.902
Hypertension0.828 (0.700–0.982)0.0300.872 (0.733–1.039)0.125
Malignancy1.879 (1.578–2.238)<0.0011.770 (1.480–2.117)<0.001
Congestive heart failure1.554 (1.320–1.829)<0.0011.433 (1.205–1.704)<0.001
SOFA score1.138 (1.114–1.162)<0.0011.114 (1.088–1.140)<0.001
Adequate antimicrobial therapy0.942 (0.789–1.124)0.505
Tight glucose control0.691 (0.488–0.976)0.0360.770 (0.543–1.090)0.141
Hydrocortisone replacement1.547 (1.225–1.954)<0.0011.009 (0.790–1.287)0.946
Lactate1.092 (1.058–1.128)<0.0011.076 (1.039–1.115)<0.001
Hemoglobin0.926 (0.890–0.963)<0.0010.936 (0.899–0.975)0.001
Creatinine1.022 (0.990–1.055)0.182
WBC1.002 (0.994–1.011)0.611
Transferrin0.996 (0.995–0.998)<0.0010.997 (0.996–0.999)<0.001
Ferritin1.000 (1.000–1.000)<0.0011.000 (0.999–1.000)0.393
Iron quartiles
   FirstReferenceReference
   Second1.148 (0.901–1.463)0.2651.149 (0.900–1.468)0.265
   Third1.307 (1.033–1.653)0.0251.309 (1.031–1.660)0.027
   Fourth1.506 (1.196–1.896)<0.0011.506 (1.190–1.908)<0.001

Abbreviations: WBC, white blood cell; SOFA, Sequential Organ Failure Assessment.

Figure 2

The hazard ratio of iron quartiles with 95% CI for overall population and patients with septic shock. The first iron quartile served as a reference.

Outcomes of patients according to the quartiles of serum iron. Abbreviations: ICU, intensive care unit; IQR, interquartile range. Kaplan-Meier curves showing the association between the iron quartiles and the 90-day mortality. Cox proportional hazard models exploring the association of iron quartiles with 90-day mortality. Abbreviations: WBC, white blood cell; SOFA, Sequential Organ Failure Assessment. The hazard ratio of iron quartiles with 95% CI for overall population and patients with septic shock. The first iron quartile served as a reference.

Discussion

In this large cohort of ICU patients, a higher serum iron quartile was associated with increased 90-day mortality in patients with sepsis. Furthermore, a dose-response analysis indicated that the risk of death on day 90 increased as the quartiles of serum iron levels upon ICU admission increased. In animal models, bacterial proliferation has been shown to be driven by iron sufficiency and suppressed by iron starvation[8-10]. In a mouse model in which the hfe gene was deleted (hfe−/−), iron abnormally accumulates in tissues. The mortality of the hfe−/− mice was approximately doubled after the mice were subjected to caecal ligation and puncture, a typically clinical used animal model of intra-abdominal sepsis[11]. In addition, iron-overloaded mice tended to develop more severe Salmonella infections[12]. Undoubtedly, the high iron level was a risk factor in the infected mouse model. Clinically, during conventional chemotherapy treatment, free iron levels > 2 μM were significantly correlated with a higher risk of sepsis caused by gram-negative bacilli for patients with acute leukaemia[13]. Furthermore, as described in previous studies[6,14], patients with haemochromatosis, a hereditary disease characterized by an iron overload, were highly susceptible to infections by various pathogens, including Escherichia coli, Vibrio vulnificus, Vibrio cholera, Klebsiella species, Listeria monocytogenes, and Shigella species. Thus, elevated iron level was probably associated with a worse prognosis in patients with sepsis. The iron level throughout the body is tightly controlled by systems that elaborately regulate iron absorption, systemic transport and cellular uptake and storage[14]. Because nearly all bacteria, fungi and protozoa require a continuous supply of host iron to successfully sustain an infection, humans have evolved powerful strategies, such as the immune system and various iron-binding proteins, to restrict the availability of iron to pathogens[15]. Micro-organisms, such as Klebsiella pneumonia and Escherichia coli, have developed intricate mechanisms to sequester iron from iron-proteins, such as transferrin, and counter the host’s iron restriction strategies. Siderophores (including aerobactin, enterobactin, salmochelin and yersiniabactin), which are excreted by bacteria, assist the pathogen in acquiring iron[16]. Neisseria meningitides can even obtain iron directly from transferrin via receptors, such as TbpA and TbpB, expressed on the bacterial outer membrane[3]. However, the majority of the transferrin that is not saturated with iron possesses a powerful bactericidal or bacteriostatic effect[2]. Transferrin has been recently shown to be a good indicator of organ failure, and higher transferrin level was associated with a decreased 30-day mortality rate in patients with decompensated cirrhosis[17]. Moreover, serum transferrin levels <150 mg/dl were associated with an increased risk of sepsis in burn patients[18]. Consistent with these findings, transferrin was associated with increased survival rates in patients with sepsis in the present study (Table 4). Although higher iron levels independently facilitate the pathogenesis of infection, some other parameters such as ferritin, the abovementioned transferrin protein and transferrin saturation (TSAT), are associated with iron. In the human body, ferritin, which is regulated by hepcidin, is an iron-binding protein whose function is to store iron in tissue, whereas transferrin in the blood transports iron. Patients who received a kidney transplant and presented ferritin levels ≥500 ng/mL had higher incidence rates (per 1,000 transplant-days) of overall infection (p = 0.017), bacterial infection (p = 0.002), and bloodstream infection (p = 0.011) during the first post-transplant year[19]. Moreover, the one-year infection-free survival rate was significantly lower in these recipients (26% vs 41%; p = 0.004)[19]. As an acute phase reactant, however, ferritin did not show impact on the survival of sepsis (HR: 1.000, 95% CI: 0.999–1.000). The reason might be its complex regulation including growth hormones, hypoxia, anaemia, and endoplasmic reticulum stress response[7]. Moreover, ferritin was defined as the major iron storage protein within hepatocytes and macrophages[20]. The fluctuation of ferritin level was complicated by hepatic disorder, tumour and hematologic instability. According to a recent prospective study of 155 ICU patients and 156 healthy individuals, TSAT was associated with increased mortality in ICU patients[7]. Actually, TSAT reflects serum iron availability and is highly correlated with iron levels (r = 0.860, p < 0.001) (see Supplementary Table S1). Generally, ICU patients, particularly septic patients, face a katabolic state that decreases iron consumption and increases iron release by destroying erythrocytes and other tissues, and this effect is further amplified by the administration of frequent blood transfusions[7]. Consistent with these findings, the regression and subgroup analyses in our study revealed that iron level was an independent risk factor for 90-day mortality. Moreover, a dose-dependent increase in the risk of death was observed as the iron level increased. The increase in iron-related mortality may be due to excess iron, which directly facilitates recurrent bacterial infections. Moreover, iron catalyses the chemical production of reactive oxygen species, such as the hydroxyl anion and superoxide, and thereby contributes to the development of multiorgan failure[11]. Thus, iron deprivation, i.e., via iron chelators, could be used to manage severe infections. For example, deferoxamine has been assessed as a chemotherapeutic adjuvant treatment in human malaria[21], and DIBI, another iron chelator, showed a significant curative effect on animal models of sepsis[22]. Although this study is a large cohort study designed to explore the relationship between the serum iron levels and outcomes in patients with sepsis, our study has several limitations. Firstly, the study was based on a publicly accessible, single-centre database, which may lead to concerns regarding the generalizability of the conclusions and the confounding bias caused by the missing data. However, this database has been explored by many authors worldwide, and articles have been published guaranteeing the data quality[23,24], potentially facilitating the generalization of our findings. Secondly, we included only patients with sepsis for whom iron measurements were available, which may be responsible for some selection bias. Thirdly, we adopted only one measurement of the iron parameters on ICU admission rather than the trends, which may ignore the effect of iron levels on the trends. Fourthly, we could only extract the administration date rather than exact hours of antimicrobials in the database. Thus, we could not incorporate the time to start of antimicrobials to the Cox regression analysis. Finally, the database was relative old (patients between 2001 and 2012) and some management strategies have been improved for sepsis recently. In summary, higher serum iron level was independently associated with an increased 90-day mortality in patients with sepsis.

Methods

Data source

This study was based on a publicly accessible critical care database named Medical Information Mart for Intensive Care III (MIMIC-III, version 1.4), which is a large, single-centre database containing information of 46,520 patients (aged 16 years or older) who were admitted to Beth Israel Deaconess Medical Center (a teaching hospital of Harvard Medical School in Boston, Massachusetts) between 2001 and 2012[25]. The database contains data pertaining to general information (i.e., demographics, billing, ICD-9 codes, ICU types, SOFA scores, SAPS II scores, etc.), treatment process (i.e., medications, procedures, laboratory tests, fluid balance, image reports, etc.) and survival data. The data were extracted from the MIMIC-III database using structure query language (SQL) with pgAdmin4 PostgreSQL 9.6.

Study patients and definitions

All patients with sepsis for whom measurement of iron parameters were available after admission to the ICU were included in the analysis. Infectious patients were defined as individuals meeting one of the following criteria: (1) ICD-9 diagnostic code containing the terms “infection”, “pneumonia”, “meningitis”, “peritonitis”, “bacteraemia”, “sepsis” or “septic”, or (2) a positive microbiological culture[26]. According to the Sepsis-3 definition, patients with infections or suspected infections and an increase of SOFA score of 2 points or more were defined as sepsis[27]. Furthermore, patients with sepsis who required vasopressors to maintain a mean arterial pressure of 65 mm Hg or greater and with serum lactate level greater than 2 mmol/L in the absence of hypovolemia were categorized as septic shock[27]. Patients who received iron supplementation during the ICU stay were excluded. For some patients for whom multiple iron measurements were available, the first measurement after ICU admission was used. Other data, including gender, age (categorized into 16–30, 31–59, and 60 years or above), admission type (elective, emergency and urgent), use of mechanical ventilation upon ICU admission, comorbidities, infection sites, pathogenic organisms, creatinine level, lactate level, white blood cell count, and SAPS II scores were extracted. Adequate antimicrobial treatments and tight glucose control were defined as previously described[28,29]. Missing values were imputed as the mean values, because all variables included less than 10% of missing observations. Patients were stratified according to the quartiles of serum iron level. The primary outcome was all cause 90-day mortality. The secondary outcomes included 28-day mortality and the length of the hospital and ICU stays.

Statistical analysis

Shapiro-Wilk tests were performed and histograms were generated to determine the normality of the distribution of the continuous variables. Normally distributed continuous variables were reported as the means ± SD, whereas skewed variables were summarized as the median and interquartile range (IQR). Categorical variables were compared using a chi-square analysis or Fisher’s exact test to determine the differences among the quartiles. For comparisons among the four quartiles of iron level, analysis of variance (ANOVA) or the Kruskal-Wallis test was performed. Outcome data were compared using a trend analysis. We compared the survival rates using log-rank tests and present the results as Kaplan–Meier curves. We developed multivariable Cox proportional hazard models for the overall population and patients with septic shock to determine the independent effect of the quartiles of serum iron level on 90-day mortality. Variables with p < 0.05 in the univariate analysis were further incorporated into multivariate Cox proportional hazard models. Iron parameters with a moderate to strong correlation strength (r > 0.3) were not simultaneously entered into the multivariable models to avoid collinearity (see Supplementary Table S1). The hazard ratios and their 95% CIs were calculated. All analyses were performed using R 3.3.3, and a p-value less than 0.05 was considered statistically significant.

Data availability

The data analysed in the study are fully available on the website.
  29 in total

Review 1.  Bacterial transferrin and lactoferrin receptors.

Authors:  S D Gray-Owen; A B Schryvers
Journal:  Trends Microbiol       Date:  1996-05       Impact factor: 17.079

2.  Influence of iron depletion on growth kinetics, siderophore production, and protein expression of Staphylococcus aureus.

Authors:  D Trivier; M Davril; N Houdret; R J Courcol
Journal:  FEMS Microbiol Lett       Date:  1995-04-01       Impact factor: 2.742

Review 3.  Role of iron in the pathogenesis of respiratory disease.

Authors:  Md Khadem Ali; Richard Y Kim; Rafia Karim; Jemma R Mayall; Kristy L Martin; Ali Shahandeh; Firouz Abbasian; Malcolm R Starkey; Veronique Loustaud-Ratti; Daniel Johnstone; Elizabeth A Milward; Philip M Hansbro; Jay C Horvat
Journal:  Int J Biochem Cell Biol       Date:  2017-05-07       Impact factor: 5.085

Review 4.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

5.  Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo.

Authors:  Thomas A Russo; Ruth Olson; Ulrike MacDonald; Janet Beanan; Bruce A Davidson
Journal:  Infect Immun       Date:  2015-06-08       Impact factor: 3.441

Review 6.  Sepsis: the critical role of iron.

Authors:  J Bullen; E Griffiths; H Rogers; G Ward
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

Review 7.  The Regulation of Iron Absorption and Homeostasis.

Authors:  Daniel F Wallace
Journal:  Clin Biochem Rev       Date:  2016-05

8.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

9.  Mortality prediction in septic shock patients: Towards new personalized models in critical care.

Authors:  M Carrara; G Baselli; M Ferrario
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015-08

10.  Antipyretic therapy in critically ill patients with sepsis: an interaction with body temperature.

Authors:  Zhongheng Zhang; Lin Chen; Hongying Ni
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

View more
  16 in total

1.  Newly Named Klebsiella aerogenes (formerly Enterobacter aerogenes) Is Associated with Poor Clinical Outcomes Relative to Other Enterobacter Species in Patients with Bloodstream Infection.

Authors:  Austin Wesevich; Granger Sutton; Felicia Ruffin; Lawrence P Park; Derrick E Fouts; Vance G Fowler; Joshua T Thaden
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

2.  The Association of Opium Abuse with Mortality Amongst Hospitalized COVID-19 Patients in Iranian Population.

Authors:  Alireza Mirahmadizadeh; Alireza Heiran; Amineh Dadvar; Mohammad Javad Moradian; Mohammad Hossein Sharifi; Roya Sahebi
Journal:  J Prev (2022)       Date:  2022-06-02

Review 3.  Iron Homeostasis and Ferritin in Sepsis-Associated Kidney Injury.

Authors:  Kayla McCullough; Subhashini Bolisetty
Journal:  Nephron       Date:  2020-07-21       Impact factor: 2.847

4.  Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.

Authors:  Joe N Frost; Tiong Kit Tan; Munawar Abbas; Sarah K Wideman; Michael Bonadonna; Nicole U Stoffel; Katherine Wray; Barbara Kronsteiner; Gaby Smits; Dean R Campagna; Tiago L Duarte; José M Lopes; Akshay Shah; Andrew E Armitage; João Arezes; Pei Jin Lim; Alexandra E Preston; David Ahern; Megan Teh; Caitlin Naylor; Mariolina Salio; Uzi Gileadi; Simon C Andrews; Susanna J Dunachie; Michael B Zimmermann; Fiona R M van der Klis; Vincenzo Cerundolo; Oliver Bannard; Simon J Draper; Alain R M Townsend; Bruno Galy; Mark D Fleming; Marie C Lewis; Hal Drakesmith
Journal:  Med (N Y)       Date:  2021-02-12

Review 5.  COVID-19-A Theory of Autoimmunity Against ACE-2 Explained.

Authors:  Philip McMillan; Thomas Dexhiemer; Richard R Neubig; Bruce D Uhal
Journal:  Front Immunol       Date:  2021-03-23       Impact factor: 7.561

6.  The Diagnostic Value of Fe3+ and Inflammation Indicators in the Death of Sepsis Patients: A Retrospective Study of 428 Patients.

Authors:  Jia Wang; Junyu Wang; Bing Wei
Journal:  Ther Clin Risk Manag       Date:  2021-01-15       Impact factor: 2.423

7.  Feasibility study and direct extraction of endogenous free metallic cations combining hemodialysis and chelating polymer.

Authors:  Marco Natuzzi; Coralie Grange; Thomas Gréa; Thomas Brichart; Axel Aigle; Denise Bechet; Benoit Hautefeuille; Eloise Thomas; Jean-Yves Ayoub; Jeanne-Marie Bonnet; Vanessa Louzier; Bernard Allaouchiche; Aymeric Couturier; Alexandra Montembault; Paula Nunes de Oliveira; Laurent David; François Lux; Olivier Tillement
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

8.  Iron deficiency after kidney transplantation.

Authors:  Joanna Sophia J Vinke; Marith I Francke; Michele F Eisenga; Dennis A Hesselink; Martin H de Borst
Journal:  Nephrol Dial Transplant       Date:  2021-11-09       Impact factor: 5.992

9.  Influence of Microbial Metabolites on the Nonspecific Permeability of Mitochondrial Membranes under Conditions of Acidosis and Loading with Calcium and Iron Ions.

Authors:  Nadezhda Fedotcheva; Andrei Olenin; Natalia Beloborodova
Journal:  Biomedicines       Date:  2021-05-17

10.  Linkage of alterations in systemic iron homeostasis to patients' outcome in sepsis: a prospective study.

Authors:  Anna Brandtner; Piotr Tymoszuk; Manfred Nairz; Georg F Lehner; Gernot Fritsche; Anja Vales; Andreas Falkner; Harald Schennach; Igor Theurl; Michael Joannidis; Günter Weiss; Christa Pfeifhofer-Obermair
Journal:  J Intensive Care       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.